U.S. market Closed. Opens in 2 hours 50 minutes

ACOR | Acorda Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-302009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-31
Revenue117.63M118.57M129.07M152.97M192.41M471.43M588.29M519.60M492.66M401.48M336.43M305.81M292.24M191.00M54.67M47.83M39.49M27.35M5.15M479.50K856.00K
Cost of Revenue46.05M30.33M40.79M33.51M34.85M99.31M135.71M108.11M92.93M80.61M66.64M57.64M66.57M35.52M11.39M11.35M8.36M7.12M5.13M5.30MN/A
Gross Profit71.59M88.23M88.28M119.45M157.56M372.12M452.57M411.49M399.73M320.87M269.79M248.17M225.67M155.49M43.28M36.47M31.13M20.23M13.38K-4.82M856.00K
Operating Expenses94.85M130.27M165.58M206.35M278.56M278.64M347.40M421.32M354.84M275.28M239.42M222.57M190.62M163.92M124.54M109.91M70.58M43.70M34.42M39.94M63.34M
Selling, General & Admin89.70M106.26M124.40M152.58M192.84M172.25M181.30M217.88M205.63M201.81M185.54M168.69M148.51M133.32M89.93M73.31M48.17M31.64M21.53M17.95MN/A
Research & Development5.15M5.80M10.42M23.01M60.08M106.38M166.10M203.44M149.21M73.47M53.88M53.88M42.11M30.60M34.61M36.60M22.41M12.05M12.89M22.00M34.27M
Other Operating Expenses51.00K18.21M30.76M30.76M25.64M-18.06M-19.07M-6.29M-14.62M-8.38M-1.50M-1.33M64.18MN/AN/AN/AN/AN/AN/AN/A29.07M
Operating Income-23.26M-42.04M-77.30M-86.90M14.55M38.49M-232.81M-35.98M33.99M36.39M30.36M25.60M35.05M-8.43M-81.26M-73.44M-39.45M-23.47M-34.41M-44.77M-62.48M
Other Expenses / Income-272.76M6.54M-15.15M-1.46M-157.64M-18.06M-19.07M-32.49M-14.62M-8.38M-1.50M-1.33M-3.04M-3.34M-2.68B8.09K50.75K75.44K1.03K2.42K-636.00K
Before Tax Income-296.02M-35.25M-109.07M-107.67M-274.25M20.42M-251.88M-42.27M19.37M28.01M28.86M24.27M32.02M-11.77M-83.94M-73.43M-39.40M-23.39M-34.41M-44.76M-63.12M
Income Tax Expenses-43.17M30.67M-5.12M-8.07M-1.28M-13.26M-28.53M-6.67M8.31M10.34M12.42M-130.69M1.41M-591.36K-1.73M893.20K-868.63K477.01K1.12M-28.55K-33.00K
Net Income-252.85M-65.92M-103.95M-99.59M-272.96M33.68M-223.36M-34.62M11.06M17.67M16.44M154.96M30.61M-11.77M-83.94M-74.34M-37.97M-24.02M-35.53M-44.74M-62.45M
Interest Expenses31.53M28.29M30.04M30.57M21.87M21.60M18.66M16.53M15.47M9.29M2.17M1.88M3.57M3.92M4.41MN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding1.24M985.35K531.05K404.20K395.93K391.75K382.99K377.16K363.51K350.63K347.35K336.10K325.00K319.62K314.46K282.82K218.64K152.88K1.70K1.65K1.61K
Diluted Shares Outstanding1.24M985.35K531.05K404.20K395.93K394.51K383.32K377.16K368.60K354.53K351.30K336.28K333.87K319.62K314.46K282.82K218.64K152.88K1.70K1.65K1.61K
EBITDA8.40M-10.03M-44.80M-64.95M40.18M148.49M443.15M16.32M55.79M54.77M30.36M25.60M38.09M-5.09M-78.58M-73.00M-39.50M-21.96M-32.60M-41.70M-61.84M
EBITDA Margin7.14%-8.46%-34.71%-42.46%20.88%31.50%75.33%3.14%11.32%13.64%9.03%8.37%13.03%-2.67%-143.72%-152.64%-100.03%-80.29%-633.53%-8,696.56%-7,224.65%
EBIT-264.49M-6.96M-79.04M-77.09M-252.38M42.02M-233.22M-24.76M34.84M37.30M31.03M26.15M35.59M-8.44M-81.26M-73.45M-38.84M-23.54M-34.41M-44.77M-62.48M
EBIT Margin-224.84%-5.87%-61.24%-50.40%-131.17%8.91%-39.64%-4.76%7.07%9.29%9.22%8.55%12.18%-4.42%-148.63%-153.57%-98.37%-86.08%-668.75%-9,336.76%-7,298.95%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-302009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙